Aditi Saha,Julio C Chavez
Aditi Saha
Introduction: CD19 has emerged as an important and novel therapeutic target in follicular lymphoma. CD19-directed therapies, including monoclonal antibodies, bispecific antibodies, and CAR T-cell therapies, offer promisin...
Cosima C Hoch,Khouloud Hachani,Yu Han et al.
Cosima C Hoch et al.
Introduction: Head and neck cancer (HNC), primarily head and neck squamous cell carcinomas, originates from the squamous epithelium in areas like the oral cavity, lip, larynx, and oropharynx. With high morbidity impacting...
Monoclonal antibodies against pediatric ulcerative colitis: a review of clinical progress [0.03%]
儿童溃疡性结肠炎单克隆抗体的临床进展综述
Debora Curci,Marianna Lucafò,Giuliana Decorti et al.
Debora Curci et al.
Introduction: In children, ulcerative colitis (UC) is often more severe and extensive than in adults and hospitalization for acute exacerbations occurs in around a quarter of subjects. There is a need for effective drugs,...
Long-term progression-free survival in non-small cell lung cancer patients: a spotlight on bevacizumab and its biosimilars [0.03%]
非小细胞肺癌患者的长期无进展生存期：贝伐单抗及其生物类似药的亮点分析
Fran Seiwerth,Lela Bitar,Miroslav Samaržija et al.
Fran Seiwerth et al.
Introduction: In the era of immunotherapy, bevacizumab seems to be losing its place in NSCLC treatment algorithms. The aim of this work is to try to define the advantages and disadvantages of NSCLC treatment with bevacizu...
Clinical experience of using biosimilars in Crohn's disease and their effectiveness [0.03%]
生物类似药治疗克罗恩病的临床应用及其有效性分析
Léa Sequier,Bénédicte Caron,Silvio Danese et al.
Léa Sequier et al.
Introduction: The approval of biosimilars in the management of inflammatory bowel diseases (IBDs) has offered an answer to a growing concern about healthcare costs, and availability of treatments. Several studies have bee...
Considerations for the use of biological therapies in elderly patients with rheumatoid arthritis [0.03%]
老年类风湿性关节炎患者使用生物制剂治疗的考虑因素
Noor Nooh,May N Lwin,Christopher Edwards
Noor Nooh
Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that primarily affects middle-aged individuals but is increasingly prevalent among the elderly due to longer life expectancies. Treating...
Caterina Labanca,Enrica Antonia Martino,Ernesto Vigna et al.
Caterina Labanca et al.
Introduction: Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma that shows a progressive increase in relapses and refractory in its natural history and a median survival of approximately 18-20 years. The advent...
Physicians' and patients' perception of biosimilars and factors affecting biosimilar prescribing in selected Asian countries: a survey study [0.03%]
亚洲选定国家医师和患者对生物仿制药的认知及其处方影响因素：一项调查研究
Supat Thongpooswan,Anupam Das,Pravin Patil et al.
Supat Thongpooswan et al.
Background: This study evaluated physicians' and patients' beliefs about biosimilars in Hong Kong, India, Pakistan, Singapore, Taiwan, and Thailand. Resea...
The immunologic role of IL-23 in psoriatic arthritis: a potential therapeutic target [0.03%]
白介素23在银屑病关节炎中的免疫作用及治疗潜力
Qin-Yi Su,Heng-Yan Gao,Yue-Ru Duan et al.
Qin-Yi Su et al.
Introduction: Psoriatic arthritis (PsA) is a debilitating chronic condition characterized by inflammation of the joints, bones, enthesis, and skin. The pivotal role of interleukin-23 (IL-23) in the pathogenesis of PsA has...
Jazmine Arévalo,Adrian Gabriel Torres
Jazmine Arévalo